10 results on '"Wiste A"'
Search Results
2. Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives
- Author
-
Schwarz, Christopher G., Kremers, Walter K., Wiste, Heather J., Gunter, Jeffrey L., Vemuri, Prashanthi, Spychalla, Anthony J., Kantarci, Kejal, Schultz, Aaron P., Sperling, Reisa A., Knopman, David S., Petersen, Ronald C., and Jack, Clifford R., Jr.
- Published
- 2021
- Full Text
- View/download PDF
3. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
- Author
-
Cogswell, Petrice M., Wiste, Heather J., Senjem, Matthew L., Gunter, Jeffrey L., Weigand, Stephen D., Schwarz, Christopher G., Arani, Arvin, Therneau, Terry M., Lowe, Val J., Knopman, David S., Botha, Hugo, Graff-Radford, Jonathan, Jones, David T., Kantarci, Kejal, Vemuri, Prashanthi, Boeve, Bradley F, Mielke, Michelle M., Petersen, Ronald C., and Jack, Clifford R., Jr
- Published
- 2021
- Full Text
- View/download PDF
4. Response to 'On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021'
- Author
-
Petrice M. Cogswell, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, and Clifford R. Jack, Jr
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2022
- Full Text
- View/download PDF
5. CSF dynamics as a predictor of cognitive progression
- Author
-
Petrice M. Cogswell, Stephen D. Weigand, Heather J. Wiste, Jeffrey L. Gunter, Jonathan Graff-Radford, David T. Jones, Christopher G. Schwarz, Matthew L. Senjem, David S. Knopman, Ronald C. Petersen, and Clifford R. Jack, Jr
- Subjects
Disproportionately enlarged subarachnoid-space hydrocephalus ,MRI ,Cognitive impairment ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Disproportionately enlarged subarachnoid-space hydrocephalus (DESH), characterized by tight high convexity CSF spaces, ventriculomegaly, and enlarged Sylvian fissures, is thought to be an indirect marker of a CSF dynamics disorder. The clinical significance of DESH with regard to cognitive decline in a community setting is not yet well defined. The goal of this work is to determine if DESH is associated with cognitive decline. Participants in the population-based Mayo Clinic Study of Aging (MCSA) who met the following criteria were included: age ≥ 65 years, 3T MRI, and diagnosis of cognitively unimpaired or mild cognitive impairment at enrollment as well as at least one follow-up visit with cognitive testing. A support vector machine based method to detect the DESH imaging features on T1-weighted MRI was used to calculate a “DESH score”, with positive scores indicating a more DESH-like imaging pattern. For the participants who were cognitively unimpaired at enrollment, a Cox proportional hazards model was fit with time defined as years from enrollment to first diagnosis of mild cognitive impairment or dementia, or as years to last known cognitively unimpaired diagnosis for those who did not progress. Linear mixed effects models were fit among all participants to estimate annual change in cognitive z scores for each domain (memory, attention, language, and visuospatial) and a global z score. For all models, covariates included age, sex, education, APOE genotype, cortical thickness, white matter hyperintensity volume, and total intracranial volume. The hazard of progression to cognitive impairment was an estimated 12% greater for a DESH score of +1 versus −1 (HR 1.12, 95% CI 0.97–1.31, p = 0.11). Global and attention cognition declined 0.015 (95% CI 0.005–0.025) and 0.016 (95% CI 0.005–0.028) z/year more, respectively, for a DESH score of +1 vs −1 (p = 0.01 and p = 0.02), with similar, though not statistically significant DESH effects in the other cognitive domains. Imaging features of disordered CSF dynamics are an independent predictor of subsequent cognitive decline in the MCSA, among other well-known factors including age, cortical thickness, and APOE status. Therefore, since DESH contributes to cognitive decline and is present in the general population, identifying individuals with DESH features may be important clinically as well as for selection in clinical trials.
- Published
- 2021
- Full Text
- View/download PDF
6. Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives
- Author
-
Christopher G. Schwarz, Walter K. Kremers, Heather J. Wiste, Jeffrey L. Gunter, Prashanthi Vemuri, Anthony J. Spychalla, Kejal Kantarci, Aaron P. Schultz, Reisa A. Sperling, David S. Knopman, Ronald C. Petersen, and Clifford R. Jack, Jr.
- Subjects
Face Recognition ,De-Facing ,De-Identification ,Anonymization ,Reliability ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Recent advances in automated face recognition algorithms have increased the risk that de-identified research MRI scans may be re-identifiable by matching them to identified photographs using face recognition. A variety of software exist to de-face (remove faces from) MRI, but their ability to prevent face recognition has never been measured and their image modifications can alter automated brain measurements. In this study, we compared three popular de-facing techniques and introduce our mri_reface technique designed to minimize effects on brain measurements by replacing the face with a population average, rather than removing it. For each technique, we measured 1) how well it prevented automated face recognition (i.e. effects on exceptionally-motivated individuals) and 2) how it altered brain measurements from SPM12, FreeSurfer, and FSL (i.e. effects on the average user of de-identified data). Before de-facing, 97% of scans from a sample of 157 volunteers were correctly matched to photographs using automated face recognition. After de-facing with popular software, 28-38% of scans still retained enough data for successful automated face matching. Our proposed mri_reface had similar performance with the best existing method (fsl_deface) at preventing face recognition (28-30%) and it had the smallest effects on brain measurements in more pipelines than any other, but these differences were modest.
- Published
- 2021
- Full Text
- View/download PDF
7. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
- Author
-
Petrice M. Cogswell, Heather J. Wiste, Matthew L. Senjem, Jeffrey L. Gunter, Stephen D. Weigand, Christopher G. Schwarz, Arvin Arani, Terry M. Therneau, Val J. Lowe, David S. Knopman, Hugo Botha, Jonathan Graff-Radford, David T. Jones, Kejal Kantarci, Prashanthi Vemuri, Bradley F Boeve, Michelle M. Mielke, Ronald C. Petersen, and Clifford R. Jack, Jr
- Subjects
Quantitative susceptibility mapping ,Beta amyloid PET ,Tau PET ,Alzheimer's disease ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Altered iron metabolism has been hypothesized to be associated with Alzheimer's disease pathology, and prior work has shown associations between iron load and beta amyloid plaques. Quantitative susceptibility mapping (QSM) is a recently popularized MR technique to infer local tissue susceptibility secondary to the presence of iron as well as other minerals. Greater QSM values imply greater iron concentration in tissue. QSM has been used to study relationships between cerebral iron load and established markers of Alzheimer's disease, however relationships remain unclear. In this work we study QSM signal characteristics and associations between susceptibility measured on QSM and established clinical and imaging markers of Alzheimer's disease. The study included 421 participants (234 male, median age 70 years, range 34–97 years) from the Mayo Clinic Study of Aging and Alzheimer's Disease Research Center; 296 (70%) had a diagnosis of cognitively unimpaired, 69 (16%) mild cognitive impairment, and 56 (13%) amnestic dementia. All participants had multi-echo gradient recalled echo imaging, PiB amyloid PET, and Tauvid tau PET. Variance components analysis showed that variation in cortical susceptibility across participants was low. Linear regression models were fit to assess associations with regional susceptibility. Expected increases in susceptibility were found with older age and cognitive impairment in the deep and inferior gray nuclei (pallidum, putamen, substantia nigra, subthalamic nucleus) (betas: 0.0017 to 0.0053 ppm for a 10 year increase in age, p = 0.03 to
- Published
- 2021
- Full Text
- View/download PDF
8. Response to “On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021”
- Author
-
Cogswell, Petrice M., Wiste, Heather J., Weigand, Stephen D., Therneau, Terry M., and Jack, Clifford R., Jr
- Published
- 2022
- Full Text
- View/download PDF
9. CSF dynamics as a predictor of cognitive progression
- Author
-
Ronald C. Petersen, Petrice M. Cogswell, Matthew L. Senjem, Jonathan Graff-Radford, Christopher G. Schwarz, David T.W. Jones, Stephen D. Weigand, Heather J. Wiste, Clifford R. Jack, Jeffrey L. Gunter, and David S. Knopman
- Subjects
Male ,Pediatrics ,Cerebral Ventricles ,Cohort Studies ,0302 clinical medicine ,Cerebrospinal Fluid Pressure ,subarachnoid-space hydrocephalus ,Longitudinal Studies ,Cognitive decline ,Cerebrospinal Fluid ,Aged, 80 and over ,education.field_of_study ,05 social sciences ,Brain ,Cognition ,Magnetic Resonance Imaging ,Cognitive test ,Cognitive impairment ,Neurology ,Pulsatile Flow ,Disease Progression ,Female ,Hydrocephalus ,MRI ,medicine.medical_specialty ,Cognitive Neuroscience ,Population ,Standard score ,050105 experimental psychology ,Subarachnoid Space ,Article ,lcsh:RC321-571 ,03 medical and health sciences ,Predictive Value of Tests ,medicine ,Dementia ,Humans ,0501 psychology and cognitive sciences ,Cognitive Dysfunction ,education ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Aged ,Proportional hazards model ,business.industry ,medicine.disease ,Disproportionately enlarged ,Disproportionately enlarged subarachnoid-space hydrocephalus ,business ,030217 neurology & neurosurgery ,Ventriculomegaly ,Follow-Up Studies - Abstract
Disproportionately enlarged subarachnoid-space hydrocephalus (DESH), characterized by tight high convexity CSF spaces, ventriculomegaly, and enlarged Sylvian fissures, is thought to be an indirect marker of a CSF dynamics disorder. The clinical significance of DESH with regard to cognitive decline in a community setting is not yet well defined. The goal of this work is to determine if DESH is associated with cognitive decline. Participants in the population-based Mayo Clinic Study of Aging (MCSA) who met the following criteria were included: age ≥ 65 years, 3T MRI, and diagnosis of cognitively unimpaired or mild cognitive impairment at enrollment as well as at least one follow-up visit with cognitive testing. A support vector machine based method to detect the DESH imaging features on T1-weighted MRI was used to calculate a “DESH score”, with positive scores indicating a more DESH-like imaging pattern. For the participants who were cognitively unimpaired at enrollment, a Cox proportional hazards model was fit with time defined as years from enrollment to first diagnosis of mild cognitive impairment or dementia, or as years to last known cognitively unimpaired diagnosis for those who did not progress. Linear mixed effects models were fit among all participants to estimate annual change in cognitive z scores for each domain (memory, attention, language, and visuospatial) and a global z score. For all models, covariates included age, sex, education, APOE genotype, cortical thickness, white matter hyperintensity volume, and total intracranial volume. The hazard of progression to cognitive impairment was an estimated 12% greater for a DESH score of +1 versus −1 (HR 1.12, 95% CI 0.97–1.31, p = 0.11). Global and attention cognition declined 0.015 (95% CI 0.005–0.025) and 0.016 (95% CI 0.005–0.028) z/year more, respectively, for a DESH score of +1 vs −1 (p = 0.01 and p = 0.02), with similar, though not statistically significant DESH effects in the other cognitive domains. Imaging features of disordered CSF dynamics are an independent predictor of subsequent cognitive decline in the MCSA, among other well-known factors including age, cortical thickness, and APOE status. Therefore, since DESH contributes to cognitive decline and is present in the general population, identifying individuals with DESH features may be important clinically as well as for selection in clinical trials.
- Published
- 2021
10. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
- Author
-
David S. Knopman, Clifford R. Jack, Stephen D. Weigand, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen, Prashanthi Vemuri, Kejal Kantarci, Jonathan Graff-Radford, Petrice M. Cogswell, Christopher G. Schwarz, Val J. Lowe, Michelle M. Mielke, Arvin Arani, Hugo Botha, Bradley F. Boeve, Heather J. Wiste, David T.W. Jones, and Matthew L. Senjem
- Subjects
Oncology ,medicine.medical_specialty ,Cognitive Neuroscience ,Amyloid pet ,Substantia nigra ,Disease ,Article ,050105 experimental psychology ,lcsh:RC321-571 ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Dementia ,0501 psychology and cognitive sciences ,Tau PET ,Cognitive impairment ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,business.industry ,Putamen ,05 social sciences ,Quantitative susceptibility mapping ,Alzheimer's disease ,medicine.disease ,Subthalamic nucleus ,Beta amyloid PET ,Neurology ,business ,Alzheimer’s disease ,030217 neurology & neurosurgery - Abstract
Altered iron metabolism has been hypothesized to be associated with Alzheimer’s disease pathology, and prior work has shown associations between iron load and beta amyloid plaques. Quantitative susceptibility mapping (QSM) is a recently popularized MR technique to infer local tissue susceptibility secondary to the presence of iron as well as other minerals. Greater QSM values imply greater iron concentration in tissue. QSM has been used to study relationships between cerebral iron load and established markers of Alzheimer’s disease, however relationships remain unclear. In this work we study QSM signal characteristics and associations between susceptibility measured on QSM and established clinical and imaging markers of Alzheimer’s disease. The study included 421 participants (234 male, median age 70 years, range 34–97 years) from the Mayo Clinic Study of Aging and Alzheimer’s Disease Research Center; 296 (70%) had a diagnosis of cognitively unimpaired, 69 (16%) mild cognitive impairment, and 56 (13%) amnestic dementia. All participants had multi-echo gradient recalled echo imaging, PiB amyloid PET, and Tauvid tau PET. Variance components analysis showed that variation in cortical susceptibility across participants was low. Linear regression models were fit to assess associations with regional susceptibility. Expected increases in susceptibility were found with older age and cognitive impairment in the deep and inferior gray nuclei (pallidum, putamen, substantia nigra, subthalamic nucleus) (betas: 0.0017 to 0.0053 ppm for a 10 year increase in age, p = 0.03 to < 0.001; betas: 0.0021 to 0.0058 ppm for a 5 point decrease in Short Test of Mental Status, p = 0.003 to p < 0.001). Effect sizes in cortical regions were smaller, and the age associations were generally negative. Higher susceptibility was significantly associated with higher amyloid PET SUVR in the pallidum and putamen (betas: 0.0029 and 0.0012 ppm for a 20% increase in amyloid PET, p = 0.05 and 0.02, respectively), higher tau PET in the basal ganglia with the largest effect size in the pallidum (0.0082 ppm for a 20% increase in tau PET, p < 0.001), and with lower cortical gray matter volume in the medial temporal lobe (0.0006 ppm for a 20% decrease in volume, p = 0.03). Overall, these findings suggest that susceptibility in the deep and inferior gray nuclei, particularly the pallidum and putamen, may be a marker of cognitive decline, amyloid deposition, and off-target binding of the tau ligand. Although iron has been demonstrated in amyloid plaques and in association with neurodegeneration, it is of insufficient quantity to be reliably detected in the cortex using this implementation of QSM.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.